Project Grant HT94252510672
Award Date
8/1/25
Completion Date
7/31/28
Dollars Obligated
$555K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Urbana, IL 61801, USA
Similar Awards
The University of Illinois was awarded a $798,912 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to investigate how PFAS (per- and polyfluoroalkyl substances) exposures can reprogram prostate stem cells and drive carcinogenesis and cancer progression. The 3-year project, running from July 1, 2023 to June 30, 2026, will advance scientific understanding of how environmental PFAS exposures may...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $573,416 project grant to The Geneva Foundation to conduct a study titled "PRE-DIAGNOSTIC SERUM CONCENTRATIONS OF PER- AND POLYFLUOROALKYL SUBSTANCES AND RISK OF TESTICULAR GERM CELL TUMORS AMONG ACTIVE-DUTY SERVICEMEN." The 3-year grant, which began on Sep 30, 2023, will support research investigating the relationship between exposure to per- and polyfluoroalkyl substances...
The federal Project Grant award, identified as HT94252410895, is funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award provides $159,900.00 to the University of Illinois to extend the period of performance for preclinical research on brain metastases in lung cancer, with a focus on investigating drug efficacy and resistance. This research aims to transform healthcare for military service members, veterans, and the broader...
This federal Project Grant award of $1,235,845.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports a research project led by the University of Illinois in Chicago. The project aims to leverage data science methods to deliver individualized treatment effects in metastatic hormone sensitive prostate cancer. The award period runs from August 15, 2025 to August 14, 2028. The Military Medical Research and Development program funds...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $660,283 to Carnegie Mellon University to conduct research on prioritizing bioaccumulative per- and polyfluoroalkyl substances (PFAS) in complex mixtures using a high-throughput bioanalytical and machine learning approach. The 3-year award period runs from August 1, 2025 to July 31, 2028. The research aims to transform healthcare for military...
The Defense Health Agency awarded a $1,117,352 Project Grant to Trustees of Boston University's Boston University Medical Campus to develop a novel and practical intervention for detoxification of per- and polyfluoroalkyl substances (PFAS) in humans. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports the university's research to transform health care for Service Members and the public through innovative biomedical research. As part of the...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,602,572.00 in funding to the University of Illinois to support research on the role of the novel hexokinase HKDC1 in hepatocellular carcinoma. The award has a performance period from July 15, 2024 to July 14, 2027. The University of Illinois, a major public research university in Chicago, will conduct innovative scientific studies to advance...
This Project Grant award, valued at $780,000.00 and effective from June 15, 2025 to June 14, 2028, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research at Georgetown University aimed at transforming healthcare for military service members, veterans, and the broader public. The research focuses on investigating "environmentally induced sperm RNAs as mediators of placentation,...
This federal Project Grant award for $1,399,812.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The grant is awarded to the Regents of the University of Minnesota to conduct research on outcomes and late effects in pediatric and adolescent germ cell tumor survivors. This funding will enable...